Table 7.
circRNA | Pattern of expression | Samples | Cell line | Targets/regulators | Function | Patient’s prognosis | Reference |
---|---|---|---|---|---|---|---|
circDGKB | ↑ | 30 NB tissues and 10 normal dorsal root ganglia as controls | SK-N-SH, SH-SY5Y | miR-873, GLI1, ZEB1 | circDGKB up-regulation improves the proliferation, migration, invasion, and tumorigenesis, though it reduces cell apoptosis. |
Lower OS | (135) |
circ-CUX1 | ↑ | 54 NB patients, GSE16476 dataset: 88 NB patients, oncogenomic database: 117 NB and 3 normal tissues | MCF 10A, HeLa, SH-SY5Y, IMR32, SK-N-AS, BE(2)-C, SK-NMC, LoVo, PC-3, HEK293, HEK293T | EWSR1, MAZ, CUX1 | circ-CUX1 knock-down inhibits aerobic glycolysis, proliferation, progression, and aggressiveness of NB. circ-CUX1 binds to EWSR1 to enable its contact with MAZ, leading to transactivation of MAZ and transcriptional modification of CUX1 and other genes linked with cancer progression. | Lower survival rate | (136) |